Literature DB >> 11474430

Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome.

J P Thornley1, D Jenkins, K Neal, T Wright, J Brough, R C Spiller.   

Abstract

Campylobacter enteritis is associated with a significant risk of developing irritable bowel syndrome, but the mechanism is unknown. This study ascertained bowel symptoms in 93 patients 3 months after Campylobacter jejuni enteritis infection. The infecting organisms were cultured, and the effects of culture supernatants on toxin-sensitive epithelial cell monolayers (HEp-2, Green monkey kidney epithelial [Vero], and CHO-K1) were investigated. In all, 50, 43, and 41 of the isolates showed toxigenic effects on HEp-2, CHO-K1, and Vero cells, respectively. Persistently changed bowel habit was reported by 9 of 50 persons with HEp-2 toxin-positive infections but by only 2 of 43 with isolates negative for toxin (chi2=4.0; P<.05). Toxicity to HEp-2 and Vero cells was associated with significantly increased numbers of days with loose stools 6 months after C. jejuni enteritis infection (both, P<.05). Thus, long-term symptoms that occur Campylobacter infection are significantly associated with bacterial toxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474430     DOI: 10.1086/322845

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  East meets West: infection, nerves, and mast cells in the irritable bowel syndrome.

Authors:  S M Collins; G Barbara
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

2.  Cognitive behavioural model of irritable bowel syndrome.

Authors:  Francis Creed
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

Review 3.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

4.  Identification of Campylobacter jejuni proteins recognized by maternal antibodies of chickens.

Authors:  Kari D Shoaf-Sweeney; Charles L Larson; Xiaoting Tang; Michael E Konkel
Journal:  Appl Environ Microbiol       Date:  2008-09-19       Impact factor: 4.792

Review 5.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

6.  ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS.

Authors:  Sam-Ryong Jee; Walter Morales; Kimberly Low; Christopher Chang; Amy Zhu; Venkata Pokkunuri; Soumya Chatterjee; Edy Soffer; Jeffrey L Conklin; Mark Pimentel
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

7.  Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders.

Authors:  Antonina A Mikocka-Walus
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

Review 8.  Post-infectious irritable bowel syndrome.

Authors:  Dolores Y Rhodes; Mark Wallace
Journal:  Curr Gastroenterol Rep       Date:  2006-08

9.  Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism.

Authors:  Shahida Baqar; David R Tribble; Marya Carmolli; Katrin Sadigh; Frederic Poly; Chad Porter; Catherine J Larsson; Kristen K Pierce; Patricia Guerry; Michael Darsley; Beth Kirkpatrick
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

10.  Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after.

Authors:  Kristine Mørch; Kurt Hanevik; Guri Rortveit; Knut-Arne Wensaas; Geir Egil Eide; Trygve Hausken; Nina Langeland
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.